Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer surgical technique or biologic surrogate?

Annals of Surgery

Volumn 262, Issue 3, 2015, Pages 476-483

  Sadot, Eran ^a   Koerkamp, Bas Groot ^a   Leal, Julie N ^a   Shia, Jinru ^a   Gonen, Mithat ^a   Allen, Peter J ^a   DeMatteo, Ronald P ^a   Kingham, T Peter ^a   Kemeny, Nancy ^a   Blumgart, Leslie H ^a   Jarnagin, William R ^a   D'Angelica, Michael I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colorectal; Hepatic; Liver; Margin; Metastases; Resection; Survival; Width

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CONFERENCE PAPER; DEMOGRAPHY; DISEASE FREE INTERVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME; CANCER CENTER; CAUSE OF DEATH; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; FACTUAL DATABASE; FOLLOW UP; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY; SURVIVAL; TIME; TREATMENT OUTCOME; TRENDS; TUMOR INVASION; UNITED STATES;

AGED; BIOPSY, NEEDLE; CANCER CARE FACILITIES; CAUSE OF DEATH; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEW YORK CITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84942540541     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001427     Document Type: Conference Paper

References (28)

1. Hamady ZZ, Lodge JP, Welsh F.K., et al. One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg. 2014; 259:543-548.
2. Dhir M, Lyden ER, Wang A, et al Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg. 2011; 254:234-242.
3. Pawlik TM, Scoggins CR, Zorzi D, et al Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005; 241:715-722; discussion 722-724
4. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995; 19:59-71.
5. Truant S, Sequier C, Leteurtre E., et al. Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. HPB (Oxford). 2015; 17:176-184.
6. de Haas R.J., Wicherts DA, Flores E, et al R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008; 248:626-637.
7. Andreou A, Aloia TA, Brouquet A, et al Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013; 257:1079-1088.
8. Nielsen K, Rolff HC, Eefsen R.L., et al. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod Pathol. 2014; 27:1641-1648.
9. Wakai T, Shirai Y, Sakata J., et al. Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol. 2008; 15:2472-2481.
10. Hayashi H, Nabeshima K, Hamasaki M., et al. Presence of microsatellite lesions with colorectal liver metastases correlate with intrahepatic recurrence after surgical resection. Oncol Rep. 2009; 21:601-607.
11. Are C, Gonen M, Zazzali K., et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007; 246:295-300.
12. Verbeke CS. Resection margins in pancreatic cancer. Surg Clin North Am. 2013; 93:647-662.
13. Fong Y, Fortner J, Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230:309-318; discussion 318-321
14. Strasberg SM, Phillips C. Use and dissemination of the Brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg. 2013; 257:377-382.
15. Cardona K, Donataccio D, Kingham T.P., et al. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. Ann Surg Oncol. 2014; 21:815-821.
16. Correa-Gallego C., Fong Y, Gonen M., et al. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol. 2014; 21:4278-4283.
17. Daly JM, Kemeny N, Oderman P., et al. Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg. 1984; 119:936-941.
18. Allen PJ, Nissan A, Picon A.I., et al. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg. 2005; 201:57-65.
19. Carpizo DR, Are C, Jarnagin W., et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol. 2009; 16:2138-2146.
20. Kokudo N, Miki Y, Sugai S., et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002; 137: 833-840.
21. Brunner SM, Kesselring R, Rubner C., et al. Prognosis according to histochemical analysis of liver metastases removed at liver resection. Br J Surg. 2014; 101:1681-1691.
22. Mlecnik B, Tosolini M, Kirilovsky A., et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011; 29:610-618.
23. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313:1960-1964.
24. Ogino S, Nosho K, Irahara N., et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res. 2009; 15:6412-6420.
25. Katz SC, Pillarisetty V, Bamboat Z.M., et al. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2009; 16:2524-2530.
26. Lunevicius R, Nakanishi H, Ito S., et al. Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol. 2001; 127:193-199.
27. Ng JK, Urbanski SJ, Mangat N, et al Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study. Cancer. 2008; 112:362-371.
28. Tomlinson JS, Jarnagin WR, DeMatteo R.P., et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007; 25:4575-4580.